Find a Clinical Trial

Physicians

Learn how we help support and foster independent practices.

Visit Site

Patients

Learn how we help make patient care our number one priority.

Visit Site

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Lymphomas

Clinical Trial at: Texas Oncology - Flower Mound

(SGN35-015) A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in older patients or patients with significant comorbidities ineligible for standard chemotherapy

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

4370 Medical Arts Drive, Suite 100
Flower Mound, Texas 75028
289.58 mi. away
P: (972) 537-4100

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Flower Mound

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

4370 Medical Arts Drive, Suite 100
Flower Mound, Texas 75028
289.58 mi. away
P: (972) 537-4100

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Flower Mound

MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX Registry)

  • Details

ClinicalTrials.gov ID: NCT03053193
Diagnosis Type: NA
USOR Number: 17079

  • Practice Details

4370 Medical Arts Drive, Suite 100
Flower Mound, Texas 75028
289.58 mi. away
P: (972) 537-4100

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Texas Oncology - Flower Mound

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

4370 Medical Arts Drive, Suite 100
Flower Mound, Texas 75028
289.58 mi. away
P: (972) 537-4100

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Flower Mound

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: NA
USOR Number: 16238

  • Practice Details

4370 Medical Arts Drive, Suite 100
Flower Mound, Texas 75028
289.58 mi. away
P: (972) 537-4100

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Rockwall

Biomarker Study to Determine Frequency of DNA-repair Defects in Men with Metastatic Prostate Cancer (64091742PCR0002)

  • Details

ClinicalTrials.gov ID: NCT03871816
Diagnosis Type: NA
USOR Number: 19144

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Solid Tumors

Clinical Trial at: Texas Oncology - Rockwall

A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations (42756493CAN2002)

  • Details

ClinicalTrials.gov ID: NCT04083976
Diagnosis Type: NA
USOR Number: 19092

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Rockwall

(MO40597) A MULTICENTRIC, OPEN-LABEL, SINGLE ARM STUDY OF OBINUTUZUMAB SHORT DURATION INFUSION (SDI) IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED FOLLICULAR LYMPHOMA (PHASE IV STUDY)

  • Details

ClinicalTrials.gov ID: NCT03817853
Diagnosis Type: NA
USOR Number: 18265

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Rockwall

Brigatinib-3001- A Phase 3 Randomized Open-label Study of Brigatinib (ALUNBRIG®)Versus Alectinib (ALECENSA®) in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer Patients Who Have Progressed on Crizotinib (XALKORI®)

  • Details

ClinicalTrials.gov ID: NCT03596866
Diagnosis Type: NA
USOR Number: 18129

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Rockwall

STAR: Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer (HER2CLIMB-02)(SGNTUC-016)

  • Details

ClinicalTrials.gov ID: NCT03975647
Diagnosis Type: NA
USOR Number: 19054

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Rockwall

(42756493BLC3001) A Phase 3 Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations (THOR)

  • Details

ClinicalTrials.gov ID: NCT03390504
Diagnosis Type: NA
USOR Number: 17133

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Texas Oncology - Rockwall

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: NA
USOR Number: 18264

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Solid Tumors

Clinical Trial at: Texas Oncology - Rockwall

(INCB 54828-207) A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

  • Details

ClinicalTrials.gov ID: NCT03822117
Diagnosis Type: NA
USOR Number: 19079

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Rockwall

A Randomized, Double-Blind, Phase 3 Study of Pemetrexed + Platinum Chemotherapy with or without Pembrolizumab (MK-3475) in TKI-resistant EGFR-mutated Tumors in Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) Participants (KEYNOTE-789; MK-3475-789)

  • Details

ClinicalTrials.gov ID: NCT03515837
Diagnosis Type: NA
USOR Number: 19020

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Rockwall

(SGN35-015) A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in older patients or patients with significant comorbidities ineligible for standard chemotherapy

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Texas Oncology - Rockwall

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Rockwall

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Rockwall

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: NA
USOR Number: 16238

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Leukemia

Clinical Trial at: Texas Oncology - Dallas

A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared with Ibrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (BGB-3111-305)

  • Details

ClinicalTrials.gov ID: NCT03734016
Diagnosis Type: NA
USOR Number: 18155

  • Practice Details

7777 Forest Lane, Suite D400
Dallas, Texas 75230
294.70 mi. away
P: (972) 566-7790

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Dallas

A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared with Ibrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (BGB-3111-305)

  • Details

ClinicalTrials.gov ID: NCT03734016
Diagnosis Type: NA
USOR Number: 18155

  • Practice Details

7777 Forest Lane, Suite D400
Dallas, Texas 75230
294.70 mi. away
P: (972) 566-7790

More Details View Practice Page

Pages

Patient Sub Menu

Patients